Operating Income (Loss) in USD of Twist Bioscience Corp from 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Twist Bioscience Corp quarterly/annual Operating Income (Loss) history and change rate from 2017 to Q3 2025.
  • Twist Bioscience Corp Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$29.9M, a 16.9% increase year-over-year.
  • Twist Bioscience Corp Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$136M, a 38.3% increase year-over-year.
  • Twist Bioscience Corp annual Operating Income (Loss) for 2025 was -$136M, a 38.3% increase from 2024.
  • Twist Bioscience Corp annual Operating Income (Loss) for 2024 was -$221M, a 1.69% decline from 2023.
  • Twist Bioscience Corp annual Operating Income (Loss) for 2023 was -$217M, a 7.5% increase from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Twist Bioscience Corp Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$136M -$29.9M +$6.11M +16.9% 01 Jul 2025 30 Sep 2025 10-K 17 Nov 2025
Q2 2025 -$142M -$30.1M +$58.8M +66.1% 01 Apr 2025 30 Jun 2025 10-Q 04 Aug 2025
Q1 2025 -$201M -$41.6M +$7.33M +15% 01 Jan 2025 31 Mar 2025 10-Q 05 May 2025
Q4 2024 -$208M -$34.6M +$12.3M +26.3% 01 Oct 2024 31 Dec 2024 10-Q 03 Feb 2025
Q3 2024 -$221M -$36M +$14.1M +28.1% 01 Jul 2024 30 Sep 2024 10-K 17 Nov 2025
Q2 2024 -$235M -$88.9M -$28.1M -46.3% 01 Apr 2024 30 Jun 2024 10-Q 04 Aug 2025
Q1 2024 -$207M -$48.9M +$12.7M +20.7% 01 Jan 2024 31 Mar 2024 10-Q 05 May 2025
Q4 2023 -$220M -$47M -$2.35M -5.26% 01 Oct 2023 31 Dec 2023 10-Q 03 Feb 2025
Q3 2023 -$217M -$50.1M +$6.76M +11.9% 01 Jul 2023 30 Sep 2023 10-K 17 Nov 2025
Q2 2023 -$224M -$60.8M +$382K +0.63% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024
Q1 2023 -$224M -$61.6M -$835K -1.37% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024
Q4 2022 -$223M -$44.6M +$11.3M +20.2% 01 Oct 2022 31 Dec 2022 10-Q 02 Feb 2024
Q3 2022 -$235M -$56.9M -$17.1M -42.9% 01 Jul 2022 30 Sep 2022 10-K 18 Nov 2024
Q2 2022 -$218M -$61.2M -$19M -45.2% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023
Q1 2022 -$199M -$60.8M -$22.8M -60% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023
Q4 2021 -$176M -$55.9M -$23.1M -70.6% 01 Oct 2021 31 Dec 2021 10-Q 07 Feb 2023
Q3 2021 -$153M -$39.8M -$15.8M -66.1% 01 Jul 2021 30 Sep 2021 10-K 21 Nov 2023
Q2 2021 -$137M -$42.1M -$13.9M -49.4% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022
Q1 2021 -$123M -$38M -$5.92M -18.4% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022
Q4 2020 -$117M -$32.8M +$23M +41.3% 01 Oct 2020 31 Dec 2020 10-Q 09 Feb 2022
Q3 2020 -$140M -$24M +$7.6M +24.1% 01 Jul 2020 30 Sep 2020 10-K/A 05 Jun 2023
Q2 2020 -$148M -$28.2M -$75K -0.27% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021
Q1 2020 -$148M -$32.1M -$5.82M -22.2% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021
Q4 2019 -$142M -$55.8M -$32.9M -144% 01 Oct 2019 31 Dec 2019 10-Q 09 Feb 2021
Q3 2019 -$109M -$31.6M -$11.9M -60.2% 01 Jul 2019 30 Sep 2019 10-K 23 Nov 2021
Q2 2019 -$97M -$28.1M -$10.6M -60.8% 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020
Q1 2019 -$86.4M -$26.3M -$9.65M -58% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020
Q4 2018 -$76.7M -$22.9M -$6.15M -36.7% 01 Oct 2018 31 Dec 2018 10-Q 10 Feb 2020
Q3 2018 -$70.6M -$19.7M 01 Jul 2018 30 Sep 2018 10-K 27 Nov 2020
Q2 2018 -$17.5M 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019
Q1 2018 -$16.6M 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019
Q4 2017 -$16.8M 01 Oct 2017 31 Dec 2017 10-Q 11 Feb 2019

Twist Bioscience Corp Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 -$136M +$84.6M +38.3% 01 Oct 2024 30 Sep 2025 10-K 17 Nov 2025
2024 -$221M -$3.67M -1.69% 01 Oct 2023 30 Sep 2024 10-K 17 Nov 2025
2023 -$217M +$17.6M +7.5% 01 Oct 2022 30 Sep 2023 10-K 17 Nov 2025
2022 -$235M -$82.1M -53.7% 01 Oct 2021 30 Sep 2022 10-K 18 Nov 2024
2021 -$153M -$12.6M -9.03% 01 Oct 2020 30 Sep 2021 10-K 21 Nov 2023
2020 -$140M -$31.2M -28.7% 01 Oct 2019 30 Sep 2020 10-K/A 05 Jun 2023
2019 -$109M -$38.3M -54.3% 01 Oct 2018 30 Sep 2019 10-K 23 Nov 2021
2018 -$70.6M -$12.1M -20.7% 01 Oct 2017 30 Sep 2018 10-K 27 Nov 2020
2017 -$58.5M 01 Oct 2016 30 Sep 2017 10-K 13 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.